Perdoceo Education (PRDO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
First quarter 2026 operating performance exceeded expectations, with revenue up 4.1% to $221.7 million, net income rising to $54.0 million, and strong student retention and enrollment growth at CTU and USAHS, offsetting declines at AIUS.
Operating income increased 22% to $63.1 million, and adjusted operating income rose 14.1% to $72.5 million, reflecting disciplined expense management and investments in technology and marketing.
Academic institutions focused on supporting adult learners and healthcare workforce development through flexible online and hybrid programs.
Strategic investments in technology and AI enhanced student experiences and operational effectiveness.
Total student enrollments reached 48,740, up 1.1% year-over-year.
Financial highlights
Net income for Q1 2026 was $54.0 million, or $0.85 per diluted share, up 23.6% year-over-year; adjusted EPS rose to $0.90 from $0.70.
Revenue was $221.7 million (+4.1% YoY); CTU +4.0%, AIUS +0.4%, USAHS +9.8%.
Operating income was $63.1 million (+22.0% YoY); adjusted operating income $72.5 million.
Net cash flows from operations were $69.4 million, up from $65.1 million in the prior year.
Cash, equivalents, and short-term investments totaled $680.0 million at quarter end.
Outlook and guidance
Full-year 2026 adjusted operating income expected between $254 million and $263 million, with adjusted EPS projected at $3.05–$3.16, a 19% increase at midpoint over 2025.
Q2 2026 adjusted operating income expected at $63–$64 million, with adjusted EPS of $0.79–$0.80, including a $0.05 non-recurring tax benefit.
Effective tax rate for 2026 projected between 22.5% and 23.5%.
Capital expenditures for 2026 expected to be about 1.5% of revenue.
Guidance assumes stable student interest and no major regulatory or federal aid disruptions.
Latest events from Perdoceo Education
- Annual meeting covers director elections, compensation, incentive plan, and auditor ratification.PRDO
Proxy filing9 Apr 2026 - Director elections, compensation, incentive plan, and auditor ratification up for shareholder vote.PRDO
Proxy filing9 Apr 2026 - 2025 saw double-digit growth in revenue, income, and enrollments, with strong 2026 guidance issued.PRDO
Q4 202519 Feb 2026 - Revenue and net income fell, but strong CTU growth and a dividend hike signal confidence.PRDO
Q2 20242 Feb 2026 - Enrollment up 11%, revenue down 5.6%, margins and outlook improve; acquisition closing soon.PRDO
Q3 202414 Jan 2026 - Q1 2025 revenue up 26.6% to $213M, driven by USAHS acquisition and enrollment growth.PRDO
Q1 202526 Dec 2025 - Q4 2024 saw record revenue and operating income, with 2025 set for further growth post-acquisition.PRDO
Q4 202423 Dec 2025 - Annual meeting to vote on directors, pay, and auditor amid growth, governance, and ESG focus.PRDO
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification.PRDO
Proxy Filing2 Dec 2025